Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

IMW 2019 | The information needs of myeloma patients

Matthias Hellberg-Naegele • 14 Sep 2019
IMW 2019
Multiple Myeloma

Matthias Hellberg-Naegele, MSc, Comprehensive Cancer Center Zurich, Zurich, Switzerland, outlines the information needs of myeloma patients along the illness trajectory and how the information needs of patients change as illness progresses. This interview was recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

More from Matthias Hellberg-Naegele

Deciding what information to provide myeloma patients 1:19
Deciding what information to provide myeloma patients
Matthias Hellberg-Naegele • 14 Sep 2019

Related Videos

The FDA approval of daratumumab for high-risk smoldering myeloma based on the AQUILA trial 10:22
The FDA approval of daratumumab for high-risk smoldering myeloma based on the AQUILA trial
Peter Voorhees • 19 Nov 2025
Promising approaches being explored in high-risk myeloma & trials to look out for 2:11
Promising approaches being explored in high-risk myeloma & trials to look out for
Sham Mailankody • 24 Oct 2025
The value of extensive profiling in single-arm trials for high-risk myeloma 2:39
The value of extensive profiling in single-arm trials for high-risk myeloma
Martin Kaiser • 24 Oct 2025
How is the definition of high-risk myeloma evolving in the era of CAR T-cell therapy? 2:35
How is the definition of high-risk myeloma evolving in the era of CAR T-cell therapy?
Sham Mailankody • 24 Oct 2025
The content of VJHemOnc is intended for healthcare professionals